Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma
NCT00415454
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class
Stopped
Poor enrollment
Conditions
Pancreatic Cancer
Interventions
GENETIC:
Ad5-yCD/mutTKSR39rep-ADP
Sponsor
Henry Ford Health System